|Articles|November 16, 2022
Trialbee Announces Trialbee Honey™ Omnichannel
Multichannel platform offers tracking for multiple recruitment sources.
Advertisement
Trialbee has announced Trialbee Honey™ Omnichannel, a multichannel approach to global patient recruitment. Honey Omnichannel enables tracking for multiple recruitment sources. The new offering is available in the company’s SaaS-based Trialbee Honey™ platform.
Read more about the new offering
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data
2
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
3
Proactive Planning is Key to Mitigating Study Rescue
4
ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
